+65.4%
CVS vs DXCM
-17.7%
+83.0%
-44.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | DXCM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.5% | -2.0% | +1.5% | -0.5% |
| 7D | +4.0% | -3.2% | +7.2% | +3.9% |
| 30D | -2.4% | +6.3% | -8.7% | -2.4% |
| 3M | +2.7% | +21.1% | -18.4% | +2.9% |
| 6M | +21.9% | +20.6% | +1.3% | +22.2% |
| YTD | +24.7% | +32.4% | -7.7% | +25.2% |
| 1Y | +35.4% | +8.8% | +26.6% | +35.6% |
| All | +65.4% | -17.7% | +83.0% | +66.0% |
Cumulative growth
Daily Returns
Daily percentage return beside DXCM.
Daily Out/Under-Performance
Portfolio return minus DXCM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × DXCM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded DXCM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling